FFAR2 and endometriosis: Blocking GPR43 and GPR109A only partially prevented n-butyrate–mediated inhibition of endometriotic cell growth in vitro and lesion growth in vivo, suggesting that n-butyrate also has GPCR-independent functions in endometriosis.